Ignite Creation Date:
2025-12-24 @ 3:32 PM
Ignite Modification Date:
2026-03-31 @ 1:39 AM
Study NCT ID:
NCT00699192
Status:
COMPLETED
Last Update Posted:
2011-06-06
First Post:
2008-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-09
First Submit QC Date:
None
Study First Post Date:
2008-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-01-11
Results First Submit QC Date:
None
Results First Post Date:
2011-06-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-04
Last Update Post Date:
2011-06-06
Last Update Post Date Type:
ESTIMATED